Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bruker Launches aurora Elite ICP-MS

Published: Tuesday, February 26, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
Company continue innovative products for trace elemental detection with launch of new aurora Elite.

At the recent European Winter Conference on Plasma Spectrochemistry 2013 (EWCPS), Bruker has launched the aurora Elite, a new ultra-sensitive Inductively Coupled Plasma Mass Spectrometer (ICP-MS).

Complementing the updated workhorse aurora M90 ICP-MS for routine laboratory analysis, the new aurora Elite sets unprecedented and truly exceptional standards for sensitivity and matrix robustness, even exceeding the performance of expensive magnetic sector field ICP-MS systems in many aspects, and far exceeding the sensitivity of all other quadrupole ICP-MS systems on the market.

The EWCPS conference focused on major topics of analytical plasma spectrochemistry, with Bruker experts and customers having presented a series of posters and talks illustrating the capabilities, applications and innovative design of both the further enhanced aurora M90 and the new addition to the Bruker ICP-MS family, the aurora Elite.

Topics covered by the posters and oral presentations included:
• 3D Ion Optics for ICP-MS
• Ion Optics for ICP-MS
• Mini Collision Cell for ICP-MS
• Isotope Ratio Determinations: High Sensitivity for Highest Precision
• Combining Highest Sensitivity with Selectivity for Quadrupole ICP-MS
• Advantages of High Sensitivity ICP-MS for Laser Ablation
• Measuring 26Mg/24Mg and 44Ca/40Ca Isotope Ratios in Environmental Samples by Q-ICP-MS
• Determination of Hg in Environmental Waters Using the Bruker aurora M90 in High Sensitivity Mode

The aurora Elite boasts a host of performance enhancements and new features, with unprecedented 1.5 gigahertz per parts per million (1.5 GHz / ppm) sensitivity for precise and accurate quantification at single digit ppt levels and below, which makes the aurora Elite the most sensitive ICP-MS instrument on the market.

This incredible sensitivity makes it eminently suitable for the semiconductor, geochemistry, materials science and related applications.

The lowest oxide ratios using its patented turner-interlaced coils ensures robust plasma conditions for complete matrix decomposition, all without the requirement of a plasma shield or guard electrode.

The combination of the aurora Elite’s high sensitivity with the all-digital detector delivers excellent results for isotope ratio determinations of low concentrations and for large ratios, and this is true for liquids and solids.

The combination of the aurora Elite’s GHz sensitivity with very short integration times makes this an ideal instrument for the analysis of nanoparticles at the smallest dimensions.

The incorporation of an easy-to-use Collision Reaction Interface (CRI II) provides a solution for simple, robust, maintenance-free interference challenges, with the convenience of either Helium- or Hydrogen mode, for improved detection limits of spectrally interfered isotopes and highest accuracy.

The expanded ICP-MS range from Bruker, including the enhanced aurora M90 and the new aurora Elite, now also offer 21 CFR Part 11 compliance to meet the requirements of pharmaceutical, biotech and CRO customers.

Dr. Meike Hamester, Director ICP-MS Global Market Development and Product Management at Bruker’s Chemical and Applied Markets (CAM) Division, commented: “The introduction of the most sensitive ICP-MS on the market provides an instrument that powers the business of quantification. Sensitivity is the key when low detection limits are the goal and the aurora Elite will be the enabler allowing trace elemental analysts to redefine their application boundaries.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bruker Reports First Quarter 2016 Financial Results
Bruker Corporation reported financial results for its first quarter ended March 31, 2016.
Wednesday, May 11, 2016
Bruker’s NMR FoodScreener™ Laboratory Achieves ISO/IEC 17025 Accreditation
Bruker announced that its NMR FoodScreener™ laboratory for food authenticity and quality determination, located in Rheinstetten, Germany, has been granted ISO/IEC 17025 accreditation.
Monday, September 28, 2015
Full Range of Bruker Systems Installed in New Pre-Clinical Imaging Laboratory
Researchers, clinicians, health educators and policy makers all gathered as the new Multidisciplinary Centre for Research into Obesity and Related Comorbidities (Cepid-OCRC) was opened at da Universidade Estadual de Campinas (UNICAMP).
Thursday, June 18, 2015
UK National Graphene Institute Selects Bruker as Official Partner
World-leading graphene research facility purchases multiple Bruker AFMs.
Tuesday, April 07, 2015
PREMIER Biosoft Announces Reseller Agreement with Bruker
Agreement aims to advance lipidomics and metabolomics research.
Monday, November 17, 2014
Bruker Sells GC Business
Bruker completed the divestiture of its GC and GC single-quadrupole (GC-SQ) mass spectrometry products to Techcomp Europe Ltd on October 31st.
Tuesday, November 04, 2014
Bruker Awarded Fourth PeakForce Tapping Patent
AFM mode uniquely combines highest resolution imaging and material property mapping.
Thursday, July 24, 2014
Using LC-MS to Analyse Sulfonamides in Food Grade Honey
Sulfonamides are one of a number of groups of chemicals whose presence in honey is limited by international regulations.
Tuesday, July 22, 2014
Bruker MALDI Biotyper™ Receives CFDA Clearance
Company receives clearance from the China Food and Drug Administration to market and sell its IVD MALDI Biotyper System as a medical device in China for the identification of microorganisms isolated from human specimens.
Thursday, June 26, 2014
Bruker Reports 7% Revenue Growth in Q4
Bruker Corporation reported financial results for its fourth quarter and full year ended December 31, 2013.
Wednesday, February 19, 2014
Bruker Opens New Preclinical Imaging Center of Excellence for the Americas
Massachusetts Center will provide advanced development, demonstration and customer support capabilities for Bracer’s unique multimodal preclinical imaging systems portfolio.
Thursday, January 30, 2014
Bruker Corporation Appoints Dr. Gilles Martin to its Board of Directors
Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group.
Monday, January 20, 2014
World’s First Compact 900 MHz Actively Refrigerated Magnet for NMR Installed at UCSD
Bruker announce the successful installation of an Ascend™ Aeon 900 magnet, the world’s first compact, single-story NMR magnet with active refrigeration.
Wednesday, December 11, 2013
Bruker Granted FDA Clearance to Market the MALDI Biotyper CA System
Bruker able to market MALDI Biotyper CA System in the US for the identification of Gram negative bacterial colonies cultured from human specimens.
Tuesday, November 26, 2013
Bruker and SISCAPA Assay Technologies Announce Second-Phase Collaboration Agreement
The ongoing collaboration aims to exploit MALDI-TOF instruments as an alternative to nano-LC-MS technology currently used in many SISCAPA assays.
Monday, September 16, 2013
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!